344 related articles for article (PubMed ID: 30481269)
1. The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children.
Brickley EB; Wright PF; Khalenkov A; Neuzil KM; Ortiz JR; Rudenko L; Levine MZ; Katz JM; Brooks WA
Clin Infect Dis; 2019 Aug; 69(5):786-794. PubMed ID: 30481269
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh.
Lewis KDC; Ortiz JR; Rahman MZ; Levine MZ; Rudenko L; Wright PF; Katz JM; Dally L; Rahman M; Isakova-Sivak I; Ilyushina NA; Matyushenko V; Fry AM; Lindstrom SE; Bresee JS; Brooks WA; Neuzil KM
Clin Infect Dis; 2019 Aug; 69(5):777-785. PubMed ID: 30481272
[TBL] [Abstract][Full Text] [Related]
3. Pre-existing influenza-specific nasal IgA or nasal viral infection does not affect live attenuated influenza vaccine immunogenicity in children.
Cole ME; Kundu R; Abdulla AF; Andrews N; Hoschler K; Southern J; Jackson D; Miller E; Zambon M; Turner PJ; Tregoning JS
Clin Exp Immunol; 2021 Apr; 204(1):125-133. PubMed ID: 33314126
[TBL] [Abstract][Full Text] [Related]
4. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
Rudenko L; Kiseleva I; Krutikova E; Stepanova E; Rekstin A; Donina S; Pisareva M; Grigorieva E; Kryshen K; Muzhikyan A; Makarova M; Sparrow EG; Torelli G; Kieny MP
PLoS One; 2018; 13(12):e0208028. PubMed ID: 30507951
[TBL] [Abstract][Full Text] [Related]
5. Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination.
Mohn KGI; Zhou F; Brokstad KA; Sridhar S; Cox RJ
J Infect Dis; 2017 May; 215(10):1527-1535. PubMed ID: 28368530
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination.
Levine MZ; Martin JM; Gross FL; Jefferson S; Cole KS; Archibald CA; Nowalk MP; Susick M; Moehling K; Spencer S; Chung JR; Flannery B; Zimmerman RK
Clin Vaccine Immunol; 2016 Oct; 23(10):831-839. PubMed ID: 27558294
[TBL] [Abstract][Full Text] [Related]
7. Live attenuated and inactivated influenza vaccines in children.
Ilyushina NA; Haynes BC; Hoen AG; Khalenkov AM; Housman ML; Brown EP; Ackerman ME; Treanor JJ; Luke CJ; Subbarao K; Wright PF
J Infect Dis; 2015 Feb; 211(3):352-60. PubMed ID: 25165161
[TBL] [Abstract][Full Text] [Related]
8. Localized mucosal response to intranasal live attenuated influenza vaccine in adults.
Barría MI; Garrido JL; Stein C; Scher E; Ge Y; Engel SM; Kraus TA; Banach D; Moran TM
J Infect Dis; 2013 Jan; 207(1):115-24. PubMed ID: 23087433
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J
Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154
[TBL] [Abstract][Full Text] [Related]
10. [Local antibody immune responses in influenza patients and persons vaccinated with seasonal, pre-pandemic, and pandemic live attenuated influenza vaccines].
Donina SA; Petukhova GD; Koren'kov DA; Grigor'eva EP; Kuznetsova SA; Losev IV; Rudenko LG; Naĭkhin AN
Vopr Virusol; 2013; 58(3):37-42. PubMed ID: 24006632
[TBL] [Abstract][Full Text] [Related]
11. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets.
Cherukuri A; Servat E; Woo J
Vaccine; 2012 Jan; 30(2):237-46. PubMed ID: 22080173
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
[TBL] [Abstract][Full Text] [Related]
14. Responses to live attenuated influenza vaccine in children vaccinated previously with Pandemrix (ASO3
Höschler K; Southern J; Thompson C; Warburton F; Andrews NJ; Miller E; Zambon M
Vaccine; 2018 May; 36(21):3034-3040. PubMed ID: 29680198
[TBL] [Abstract][Full Text] [Related]
15. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
Mallory RM; Yi T; Ambrose CS
Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
[TBL] [Abstract][Full Text] [Related]
16. A study to evaluate the immunogenicity and shedding of live attenuated influenza vaccine strains in children 24-<48 months of age.
Mallory RM; Nyborg A; Kalyani RN; Yuan Y; Block SL; Dubovsky F
Vaccine; 2020 Jan; 38(5):1001-1008. PubMed ID: 31796225
[TBL] [Abstract][Full Text] [Related]
17. Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.
Hoschler K; Maharjan S; Whitaker H; Southern J; Okai B; Baldevarona J; Turner PJ; Andrews NJ; Miller E; Zambon M
Vaccine; 2020 Mar; 38(12):2660-2670. PubMed ID: 32070679
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults.
Hoft DF; Lottenbach KR; Blazevic A; Turan A; Blevins TP; Pacatte TP; Yu Y; Mitchell MC; Hoft SG; Belshe RB
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27847366
[TBL] [Abstract][Full Text] [Related]
19. Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.
Rudenko L; Naykhin A; Donina S; Korenkov D; Petukhova G; Isakova-Sivak I; Losev I; Stukova M; Erofeeva M; Nikiforova A; Power M; Flores J
Hum Vaccin Immunother; 2015; 11(12):2839-48. PubMed ID: 26697973
[TBL] [Abstract][Full Text] [Related]
20. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
